Literature DB >> 32294746

Dopaminergic drugs alter beta coherence during motor imagery and motor execution in healthy adults.

Danielle Aprigio1,2, Guaraci Ken Tanaka1,2, Juliana Bittencourt2,3, Mariana Gongora3,4, Silmar Teixeira1,5, Mauricio Cagy6, Henning Budde7,8,9, Marco Orsini10,11, Pedro Ribeiro1,2,12, Bruna Velasques1,2,4.   

Abstract

BACKGROUND: Motor Imagery (MI) represents the cognitive component of the movement and recruits dopaminergic systems.
OBJECTIVE: To investigate the role of dopaminergic system through the action of methylphenidate and risperidone over beta coherence during execution, action observation and motor imagery.
METHODS: Electroencephalography (EEG) data were recorded before and after the substance intake. For statistical analysis, a three-way ANOVA was used to identify changes in beta coherence induced by the group, task and the moment variables. Statistical significance was set at p≤0.007.
RESULTS: We found a main effect for group for C3/CZ, and a main effect for task for CZ/C4 pairs of electrodes. Furthermore, significant differences were found in the post-drug administration between groups for C3/CZ pair of electrodes, and between task for C4/CZ pair of electrodes.
CONCLUSION: The administration of methylphenidate and risperidone was able to produce electrocortical changes of the cortical central regions, even when featuring antagonistic effects on the dopaminergic pathways. Moreover, the execution task allowed beta-band modulation increase.

Entities:  

Year:  2020        PMID: 32294746     DOI: 10.1590/0004-282X20190186

Source DB:  PubMed          Journal:  Arq Neuropsiquiatr        ISSN: 0004-282X            Impact factor:   1.420


  1 in total

1.  Methylphenidate decreases the EEG mu power in the right primary motor cortex in healthy adults during motor imagery and execution.

Authors:  Danielle Aprigio; Juliana Bittencourt; Mariana Gongora; Victor Marinho; Silmar Teixeira; Victor Hugo Bastos; Mauricio Cagy; Henning Budde; Pedro Ribeiro; Luis Fernando Basile; Bruna Velasques
Journal:  Brain Struct Funct       Date:  2021-02-17       Impact factor: 3.270

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.